| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.16 | 0.001 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.16 | 0.003 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.15 | 0.004 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.096 | 0.006 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | -0.44 | 0.006 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.086 | 0.006 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.35 | 0.007 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.008 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.009 |